Login
$TVTX
$50.88 +$0.91 (1.82%) Close

Insider Transactions

What Travere Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.

Insider trades

3 months 12 months
Open-market buys 0 0
Sells 49 124
Total trades 76 221

Shares traded

3 months 12 months
Acquired 1,218,694 2,383,504
Disposed 1,304,671 2,342,185
Net activity −85,977 +41,319

See the story behind these numbers

View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.

Open-market buyer Disclosed 10b5-1 Heavy discretionary Sign up free

All transactions

Insider Relation Date Transaction Shares Price Value Shares held
Dube Eric M CHIEF EXECUTIVE OFFICER Oct 15 Open-market sale · S −78,400 $55.02 −$4.31M 432,886
Dube Eric M CHIEF EXECUTIVE OFFICER Oct 15 Open-market sale · S −37,270 $54.20 −$2.02M 511,286
Dube Eric M CHIEF EXECUTIVE OFFICER Oct 15 Open-market sale · S −128,065 $52.97 −$6.78M 548,556
Dube Eric M CHIEF EXECUTIVE OFFICER Oct 15 Exercise / conversion · M +200,000 $8.93 +$1.79M 676,621
Dube Eric M CHIEF EXECUTIVE OFFICER Oct 15 Exercise / conversion · M +43,735 $26.88 +$1.18M 476,621
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 17 Open-market sale · S −6,802 $64.95 −$442K 432,886
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 17 Open-market sale · S −101,691 $64.59 −$6.57M 439,688
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 17 Exercise / conversion · M +108,493 $23.34 +$2.53M 541,379
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sep 17 Open-market sale · S −8,282 $65.07 −$539K 117,066
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sep 17 Exercise / conversion · M +8,282 $22.40 +$186K 125,348
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 16 Open-market sale · S −96,125 $63.64 −$6.12M 432,886
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 16 Open-market sale · S −99,716 $63.26 −$6.31M 529,011
Dube Eric M CHIEF EXECUTIVE OFFICER Sep 16 Exercise / conversion · M +195,841 $23.34 +$4.57M 628,727
Rote William E. Chief Research Officer Sep 16 Open-market sale · S −47,746 $63.61 −$3.04M 98,197
Rote William E. Chief Research Officer Sep 16 Open-market sale · S −65,104 $63.12 −$4.11M 145,943
Rote William E. Chief Research Officer Sep 16 Exercise / conversion · M +57,500 $26.88 +$1.55M 211,047
Rote William E. Chief Research Officer Sep 16 Exercise / conversion · M +55,000 $15.46 +$850K 153,547
Rote William E. Chief Research Officer Sep 16 Exercise / conversion · M +350 $17.96 +$6.29K 98,547
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sep 16 Open-market sale · S −79,113 $63.65 −$5.04M 117,066
Heerma Peter EVP, CHIEF COMMERCIAL OFFICER Sep 16 Open-market sale · S −93,604 $63.25 −$5.92M 196,179

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support